2022年1月27日15時配信開始 以降はオンデマンドで視聴可能です。
所要時間: 30 分
細胞培養分析の自動化、スケールアップに関するノバの最新技術をご紹介いたします。
*本ウェビナーは日本語ナレーションでお届けします。BioPharma week2021ウェブセミナーと同じ内容です
Matt McRae（マット マクリー）
Product Line Manager, Biotechnology Products
Nova Biomedical
Date: Thursday, February 17, 2022 & Thursday, March 03, 2022
Time: 02:00 PM Eastern Standard Time
Duration: 1 hour
Acute kidney injury (AKI) is a common complication in critically ill patients and is associated with high morbidity and mortality. AKI is often multifactorial, asymptomatic and difficult to predict. This webinar provides a review of the etiologies of AKI and a systematic approach toward its diagnosis and management with emphasis on fluid volume assessment and management. The use of point-of-care (POC) biomarkers have provided additional tools to detect patients at high risk of AKI and improve their outcomes. We will review protocols that integrate the use of POC biomarkers into a multidisciplinary clinical response team to potentially reduce AKI development, severity and the number of patients who need dialysis.
Whether in the ICU or other hospital wards, AKI represents a complex disorder that requires frequent monitoring and early detection to achieve optimal outcomes. There are many testing modalities available for the clinician to aid in AKI clinical decision making and management. These involve following trends in blood creatinine, plasma volume status, and electrolytes including ionized magnesium. This webinar will also investigate point-of-care testing options available to clinicians that care for these patients.
Rolando Claure-Del Granado, MD, FASN
Director, AKI/CRRT Program
Hospital Obrero, Cochabamba, Bolivia
Dr. Claure-Del Granado is also Professor of Medicine, Universidad Mayor de San Simon, School of Medicine, Bolivia and Member at Large, International Society of Nephrology Executive Committee
Dennis Begos, MD, FACS, FACRS
Medical Director, Medical and Scientific Affairs
Nova Biomedical